Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis
- 1 January 1997
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 130 (1) , 52-58
- https://doi.org/10.1016/s0022-3476(97)70310-x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acidGastroenterology, 1995
- Ursodiol for the Long-Term Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1994
- A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatmentJournal of Hepatology, 1994
- Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytesHepatology, 1993
- Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administrationHepatology, 1991
- Paradoxical effects of essential fatty acid supplementation on lipid profiles and sweat electrolytes in cystic fibrosisBritish Journal of Nutrition, 1990
- Gallstone dissolution therapyGastroenterology, 1986
- Morphological findings in the liver of children with cystic fibrosis: A light and electron microscopical studyHepatology, 1986
- Relationships Between Pulmonary Function and Plasma Fatty Acid Levels in Cystic Fibrosis PatientsJournal of Pediatric Gastroenterology and Nutrition, 1986
- Correction of Linoleic Acid Deficiency in Cystic FibrosisPediatric Research, 1986